GlassScriptPhysician profile
Natalie Thurmond
NPI 1396477535
$1,092.93
in general payments reported to CMS, 2019-2025
19 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $72.18 · 2023: $332 · 2024: $244 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.75 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $391.66 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $142.82 | 2023-2025 | |
| Abbvie INC. | $67.19 | 2022-2023 | |
| Integra Lifesciences Corporation | $57.11 | 2023 | Biodoptix, Medihoney, Biodfactor |
| Millicent US INC | $46.50 | 2024-2025 | Intrarosa |
| Biogen, INC. | $45.97 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $45.71 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $39.17 | 2023-2025 | |
| Pfizer INC. | $36.86 | 2024 | |
| Exeltis, USA INC. | $35.52 | 2025 | Slynd, Twirla |
| Merck Sharp & Dohme LLC | $30.26 | 2022-2024 | Gardasil 9, Gardasil |
| Shield Therapeutics INC | $22.43 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $21.98 | 2025 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $20.16 | 2022 | |
| Sumitomo Pharma America, INC. | $19.78 | 2023 | Myfembree |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18.38 | 2025 | Interstim |
| Exact Sciences Corporation | $17.86 | 2025 | The Cologuard Plus Collection Kit |
| Evofem Biosciences, INC. | $17.77 | 2022 | |
| Solventum Corporation | $15.80 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Thurmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.